Structure-based and ligand-based drug design for microsomal prostaglandin E synthase-1 inhibitors

Author： Li Chia-Ling   Chang Tung-Ti   Sun Mao-Feng   Chen Hsin-Yi   Tsai Fuu-Jen   Fisher Mark   Chen Calvin Yu-Chian   Lee Chun-Lin   Fang Wen-Chang   Wong Yung-Hao  

Publisher： Taylor & Francis Ltd

ISSN： 0892-7022

Source： Molecular Simulation, Vol.37, Iss.3, 2011-03, pp. : 226-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design

By Bauman Joseph D.  

Nucleic Acids Research, Vol. 36, Iss. 15, 2008-09 ,pp. : 5083-5092

Oxford University Press

Access to resources Recommend Favorite

Methods for the Prediction of Protein-Ligand Binding Sites for Structure-Based Drug Design and Virtual Ligand Screening.

By  

Current Protein and Peptide Science, Vol. 7, Iss. 5, 2006-10 ,pp. : 395-406

Bentham Science Publishers

Access to resources Recommend Favorite

Purification and characterization of recombinant microsomal prostaglandin E synthase-1

By Ouellet M.   Falgueyret J-P.   Hien Ear P.   Pen A.   Mancini J.A.   Riendeau D.   David Percival M.  

Protein Expression and Purification, Vol. 26, Iss. 3, 2002-12 ,pp. : 489-495

Academic Press

Access to resources Recommend Favorite

Structure-Based Drug Design: Docking and Scoring

By  

Current Protein and Peptide Science, Vol. 8, Iss. 4, 2007-08 ,pp. : 312-328

Bentham Science Publishers

Access to resources Recommend Favorite

Stable isotope labelling of human histamine receptor H1R: Prospects for structure-based drug design

By Egorova-Zachernyuk T.   Bosman G.   DeGrip W.   Shvets V.  

Doklady Biochemistry & Biophysics, Vol. 433, Iss. 1, 2010-08 ,pp. : 164-167

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite